Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.4
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income
Total New Residential Stockholders’ Equity
Total New Residential Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Common Stock
Retained Earnings (Accumulated Deficit)
Common Stock
Total New Residential Stockholders’ Equity
Preferred Stock
Preferred Stock
Preferred Stock
Preferred Stock
Retained Earnings (Accumulated Deficit)
Preferred Stock
Total New Residential Stockholders’ Equity
Balance, beginning (in shares) at Dec. 31, 2017     0 307,361,309                                  
Balance, beginning at Dec. 31, 2017 $ 4,796,162   $ 0 $ 3,074 $ 3,763,188 $ 559,476   $ 364,467 $ 4,690,205   $ 105,957                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
2020 Warrants 0                                        
Dividends declared on common stock                         $ (692,730)     $ (692,730) $ (692,730)        
Capital distributions (64,559)                   (64,559)                    
Issuance stock (in shares)                           57,991,659              
Issuance of stock                         982,062 $ 580 $ 981,482   982,062        
Option exercise (in shares)       3,694,228                                  
Option exercise       $ 37 (37)                                
Purchase of  Noncontrolling Interest in the Buyer at a Discount 9,316       653       653   8,663                    
Other dilution (63)       (63)       (63)                        
Director share grants (in shares)       57,233                                  
Director share grants 1,020     $ 1 1,019       1,020                        
Comprehensive income (loss)                                          
Net income (loss) 1,004,531         963,967     963,967   40,564                    
Net unrealized gain (loss) on securities (7,397)             (7,397) (7,397)                        
Reclassification of net realized (gain) loss on securities into earnings 59,953             59,953 59,953                        
Total comprehensive income (loss) 1,057,087               1,016,523   40,564                    
Balance, ending (in shares) at Dec. 31, 2018     0 369,104,429                                  
Balance, ending at Dec. 31, 2018 6,088,295   $ 0 $ 3,692 4,746,242 830,713   417,023 5,997,670   90,625                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
2020 Warrants 0                                        
Dividends declared on common stock                         (830,995)     $ (830,995) (830,995)        
Dividends declared on preferred stock                                   $ (13,281)   $ (13,281) $ (13,281)
Capital distributions $ (54,712)                   (54,712)                    
Issuance stock (in shares)                           46,000,000         17,510,000    
Issuance of stock                         751,393 $ 460 750,933   751,393 423,444 $ 423,444   423,444
Option exercise (in shares) 2,041,222     348,613                                  
Option exercise       $ 3 (3)                                
Director share grants (in shares)       67,738                                  
Director share grants $ 1,055     $ 1 1,054       1,055                        
Comprehensive income (loss)                                          
Net income (loss) 605,933         563,296     563,296   42,637                    
Net unrealized gain (loss) on securities 445,943             445,943 445,943                        
Reclassification of net realized (gain) loss on securities into earnings (180,815)             (180,815) (180,815)                        
Total comprehensive income (loss) 871,061               828,424   42,637                    
Balance, ending (in shares) at Dec. 31, 2019     17,510,000 415,520,780                                  
Balance, ending at Dec. 31, 2019 $ 7,236,260 $ 30,453 $ 423,444 $ 4,156 5,498,226 549,733 $ 13,658 682,151 7,157,710 $ 13,658 78,550 $ 16,795                  
Comprehensive income (loss)                                          
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                                        
2020 Warrants $ 53,462       53,462       53,462                        
Dividends declared on common stock (207,667)         (207,667)     (207,667)                        
Dividends declared on preferred stock (54,295)         (54,295)     (54,295)                        
Capital contributions 2,449                   2,449                    
Capital distributions $ (41,800)                   (41,800)                    
Issuance stock (in shares)                           97,394         16,100,000    
Issuance of stock                         1,663 $ 1 1,662   1,663 $ 389,548 $ 389,548   $ 389,548
Repurchase of common stock (in shares)                           (1,000,000)              
Repurchase of common stock                         $ (7,462) $ (10) $ (7,452)   $ (7,462)        
Option exercise (in shares) 0                                        
Director share grants (in shares)       126,344                                  
Director share grants $ 1,211     $ 1 1,210       1,211                        
Net income (loss) (1,357,684)         (1,410,358)     (1,410,358)   52,674                    
Net unrealized gain (loss) on securities 123,855             123,855 123,855                        
Reclassification of net realized (gain) loss on securities into earnings (740,309)             (740,309) (740,309)                        
Total comprehensive income (loss) (1,974,138)               (2,026,812)   52,674                    
Balance, ending (in shares) at Dec. 31, 2020     33,610,000 414,744,518                                  
Balance, ending at Dec. 31, 2020 $ 5,429,684   $ 812,992 $ 4,148 $ 5,547,108 $ (1,108,929)   $ 65,697 $ 5,321,016   $ 108,668